Details van artikel 440 van 967 gevonden artikelen
OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
Titel:
OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
Auteur:
Saenger, P.H. Khadilkar, V. Radjuk, K.A. Bolshova, E. Khadgawat, R. El Kholy, M. Peterkova, V. Desai, M. Mericq, V. Savoy, C. Ji, H.-J. Zadik, Z. Kratzsch, J. Bidlingmaier, M.
Verschenen in:
Growth hormone & IGF research
Paginering:
Jaargang 20 (2010) nr. S1 pagina's 2 p.
Jaar:
2010
Inhoud:
Uitgever:
Elsevier Ltd
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 440 van 967 gevonden artikelen